Back
International Consolidated Airlines Group SA 10K Form
Buy
62
ICAGY
International Consolidated Airlines Group SA
Last Price:
5.38
Seasonality Move:
20.42%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ICAGY News And Ratings
See the #1 stock for the next 7 days that we like better than ICAGY
ICAGY Financial Statistics
Sales & Book Value
| Annual Sales: | $31.89B |
|---|---|
| Cash Flow: | $3.41B |
| Price / Cash Flow: | 2.15 |
| Annual Sales: | $2.08 |
| Price / Book: | 2.59 |
Profitability
| EPS (TTM): | 0.80390 |
|---|---|
| Net Income (TTM): | $1.98B |
| Gross Margin: | $7.25B |
| Return on Equity: | 80.02% |
| Return on Assets: | 4.44% |
International Consolidated Airlines Group SA Earnings Forecast
Key International Consolidated Airlines Group SA Financial Ratios
- The Gross Profit Margin over the past 13 years for ICAGY is 22.74%.
- The Selling, General & Administrative Expenses for ICAGY have been equal to 3.92% of Gross Profit Margin.
- The Research & Development expenses have been 0.76% of Revenue.
- The Interest Expense is 41.24% of Operating Income.
- The Net Earning history of ICAGY is 9.01% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 10 years.
International Consolidated Airlines Group SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Passenger Airlines |
| Sector: | Industrials |
| Current Symbol: | ICAGY |
| Website: | iairgroup.com |
Debt
| Debt-to-Equity Ratio: | 1.58 |
|---|---|
| Current Ratio: | 0.7 |
| Quick Ratio: | 0.57 |
Price-to-Earnings
| Trailing P/E Ratio: | 4.93 |
|---|---|
| Forward P/E Ratio: | 0 |
ICAGY Technical Analysis vs Fundamental Analysis
Buy
62
International Consolidated Airlines Group SA (ICAGY)
is a Buy
Is International Consolidated Airlines Group SA a Buy or a Sell?
-
International Consolidated Airlines Group SA stock is rated a Buy
The current International Consolidated Airlines Group SA [ICAGY] share price is $5.40. The Score for ICAGY is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.